IRIS
GIACOMELLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 15.072
NA - Nord America 7.927
EU - Europa 3.786
SA - Sud America 1.804
AF - Africa 222
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 28.869
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 8.447
US - Stati Uniti d'America 7.564
CN - Cina 2.670
HK - Hong Kong 2.212
IT - Italia 1.686
BR - Brasile 1.351
VN - Vietnam 762
GB - Regno Unito 643
FR - Francia 537
DE - Germania 261
IN - India 219
CA - Canada 199
AR - Argentina 182
BD - Bangladesh 176
NL - Olanda 115
ID - Indonesia 112
MX - Messico 97
EC - Ecuador 83
ZA - Sudafrica 80
TR - Turchia 76
UA - Ucraina 74
JP - Giappone 72
CO - Colombia 59
ES - Italia 57
IQ - Iraq 56
RU - Federazione Russa 53
AU - Australia 50
PL - Polonia 45
CL - Cile 39
FI - Finlandia 37
PY - Paraguay 36
SA - Arabia Saudita 34
MA - Marocco 32
AT - Austria 31
CZ - Repubblica Ceca 31
SE - Svezia 29
PE - Perù 26
PK - Pakistan 25
EG - Egitto 23
MD - Moldavia 22
PT - Portogallo 22
TN - Tunisia 22
UZ - Uzbekistan 20
RO - Romania 19
PH - Filippine 18
JM - Giamaica 17
VE - Venezuela 16
IL - Israele 14
JO - Giordania 14
KE - Kenya 13
KZ - Kazakistan 13
LT - Lituania 13
OM - Oman 12
DK - Danimarca 11
IR - Iran 11
NP - Nepal 11
BG - Bulgaria 10
LB - Libano 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
DZ - Algeria 9
IE - Irlanda 9
AZ - Azerbaigian 8
CH - Svizzera 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
GT - Guatemala 8
HN - Honduras 8
TH - Thailandia 8
CR - Costa Rica 7
GR - Grecia 7
MY - Malesia 7
SK - Slovacchia (Repubblica Slovacca) 7
UY - Uruguay 7
EE - Estonia 6
KR - Corea 6
KW - Kuwait 6
RS - Serbia 6
SV - El Salvador 6
BE - Belgio 5
GH - Ghana 5
LU - Lussemburgo 5
LV - Lettonia 5
SN - Senegal 5
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
CG - Congo 4
PA - Panama 4
SI - Slovenia 4
TW - Taiwan 4
AF - Afghanistan, Repubblica islamica di 3
BH - Bahrain 3
CY - Cipro 3
HU - Ungheria 3
IS - Islanda 3
PS - Palestinian Territory 3
QA - Qatar 3
SY - Repubblica araba siriana 3
YT - Mayotte 3
BW - Botswana 2
Totale 28.804
Salva come PNG Salva come JPEG
Città #
San Jose 2.933
Hong Kong 2.188
Ashburn 1.816
Singapore 1.706
Rome 1.266
Hefei 1.104
Boardman 617
London 526
Lauterbourg 473
Beijing 466
Shanghai 357
Dallas 337
Ho Chi Minh City 293
Council Bluffs 207
Hanoi 149
New York 147
Los Angeles 126
São Paulo 112
Santa Clara 98
Pune 97
San Francisco 94
Amsterdam 78
Toronto 68
Munich 61
Washington 53
Tokyo 52
Seattle 50
Mexico City 43
Warsaw 37
Frankfurt am Main 36
Haiphong 36
Montreal 35
Naples 34
Rio de Janeiro 34
Brooklyn 33
Da Nang 33
Brasília 32
Baghdad 30
Ankara 29
Johannesburg 28
Milan 28
Guayaquil 27
Chicago 24
Quito 24
Stockholm 24
Turku 23
Biên Hòa 22
Guangzhou 22
Nuremberg 21
Porto Alegre 21
Atlanta 20
Bari 20
Curitiba 20
Thái Bình 20
West Jordan 20
Brno 19
Chennai 19
Phoenix 19
Boston 18
Buenos Aires 18
Cape Town 18
Hải Dương 18
Jinan 18
Belo Horizonte 17
Campinas 17
Manchester 17
Sydney 17
Vienna 17
Guarulhos 16
Lima 16
Tashkent 16
Buffalo 15
Hangzhou 15
Jakarta 15
Changsha 14
Charlotte 14
Riyadh 14
Can Tho 13
Dhaka 13
Helsinki 13
Manaus 13
Medellín 13
Melbourne 13
Amman 12
Hortolândia 12
Lấp Vò 12
Paris 12
Salvador 12
Tunis 12
Bengaluru 11
Bogotá 11
Cairo 11
Fortaleza 11
Madrid 11
Nairobi 11
Qingdao 11
Santiago 11
Asunción 10
Barcelos 10
Kingston 10
Totale 16.885
Salva come PNG Salva come JPEG
Nome #
Fibroblast expression of CD248 may contribute to exacerbate microvascular damage during systemic sclerosis 267
------- 241
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 235
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 233
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 220
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 220
A comprehensive review on adult onset Still's disease 214
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 207
Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis 204
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 200
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 195
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 192
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 192
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 191
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 191
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 191
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 182
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 177
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 174
A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 174
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 167
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 165
Adult-onset Still's disease with elderly onset: results from a multicentre study 163
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 163
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19 153
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 134
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 124
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 122
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 118
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 117
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 116
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 114
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 113
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 112
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 109
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 109
Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts 109
Activation antigens and adhesion molecules expression on Vd1+ T cells in systemic sclerosis (SSc) 106
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 104
Cytokine storm syndrome in severe COVID-19 104
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 103
EVIDENCE FOR REDUCED ANGIOGENESIS IN BONE MARROW (BM) IN SYSTEMIC SCLEROSIS (SSC) 102
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data 101
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 100
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 97
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 96
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 95
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 93
Cardiovascular disease in primary sjögren’s syndrome 90
The Effect of Ketogenic Diet on Inflammatory Arthritis and Cardiovascular Health in Rheumatic Conditions: A Mini Review 90
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 88
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 84
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 84
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 83
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 81
The economic burden of fibromyalgia: A systematic literature review 81
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 81
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis 80
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease 78
The Relationship Between Metabolic Syndrome and Pain Catastrophizing in Psoriatic Arthritis 77
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 77
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 77
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach 74
Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis 74
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 71
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 71
EULAR Textbook on Rheumatic Diseases – Third Edition (2018) 71
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome 71
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 70
Association Between the Use of Oral Contraceptives and the Development of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 69
The Vessels Contribute to Fibrosis in Systemic Sclerosis 69
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry 69
SCLERODERMA FIBROBLASTS SUPPRESS ANGIOGENESIS VIA TGF-beta/CAVEOLIN-DEPENDENT SECRETION OF PIGMENTED EPITHELIUM DERIVED FACTOR: TGF-beta RECEPTOR INHIBITORS AS A NOVEL THERAPEUTIC TARGET FOR THE TREATMENT OF SCLERODERMA 68
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 68
Development and implementation of the AIDA International Registry for patients with Behçet's disease 67
Vascular complications of scleroderma 67
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis 67
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 66
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 66
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 66
Systemic Sjogren presenting without sicca syndrome: characterization of 240 patients according to the new 2017 ACR/EULAR Classification Criteria 65
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 64
Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications 64
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 64
The measurement of fibromyalgia severity: converting scores between the FIQR, the PSD and the FASmod 64
Primary versus systemic-sclerosis-associated Raynaud's phenomenon: relationship with clinical and environmental factors 63
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 63
Recent advances and evolving concepts in Still's disease 62
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function 62
Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis. 62
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 62
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 62
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 61
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions 61
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 61
Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study 61
Co-Occurrence of Anti-Synthetase Syndrome and Sjögren Disease: A Case-Based Review 60
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders 60
IL-36α axis is modulated in patients with primary Sjogren's Syndrome. 60
The kaleidoscope of neurological manifestations in primary Sjögren's syndrome 60
Totale 11.045
Salva come PNG Salva come JPEG
Categoria #
all - tutte 231.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 231.517
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022648 0 5 29 4 7 2 4 4 55 29 19 490
2022/2023318 5 15 11 28 73 13 6 7 10 11 130 9
2023/20241.786 60 216 61 144 198 839 32 85 17 51 40 43
2024/202510.867 230 179 617 113 109 364 242 64 1.422 1.088 3.012 3.427
2025/202615.414 1.556 496 1.216 2.243 456 944 4.069 1.311 1.231 1.258 634 0
Totale 29.033